These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23392964)

  • 21. Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease.
    Campochiaro C; Della-Torre E; Lanzillotta M; Bozzolo E; Baldissera E; Milani R; Arcidiacono PG; Crippa S; Falconi M; Dagna L
    Eur J Intern Med; 2020 Apr; 74():92-98. PubMed ID: 31901297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retroperitoneal fibrosis. Steroid treatment response seems to depend on its association to IgG4 related disease.
    Soriano Rios A; Paredes H; Hernández-Calleros J; Uscanga-Domínguez L; Peláez-Luna M
    Med Hypotheses; 2019 Jan; 122():120-123. PubMed ID: 30593393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tacrolimus as a reasonable alternative in a patient with steroid-dependent and thiopurine-refractory autoimmune pancreatitis with IgG4-associated cholangitis.
    Buechter M; Klein CG; Kloeters C; Schlaak JF; Canbay A; Gerken G; Kahraman A
    Z Gastroenterol; 2014 Jun; 52(6):564-8. PubMed ID: 24905108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment and outcomes in patients with IgG4-related disease using the IgG4 responder index.
    Fernández-Codina A; Pinilla B; Pinal-Fernández I; López C; Fraile-Rodríguez G; Fonseca-Aizpuru E; Carballo I; Brito-Zerón P; Feijóo-Massó C; López-Dupla M; Cid MC; Martínez-Valle F; ; ;
    Joint Bone Spine; 2018 Dec; 85(6):721-726. PubMed ID: 29452298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial.
    Sanders JS; de Joode AA; DeSevaux RG; Broekroelofs J; Voskuyl AE; van Paassen P; Kallenberg CG; Tervaert JW; Stegeman CA
    Nephrol Dial Transplant; 2016 Sep; 31(9):1453-9. PubMed ID: 27242368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy between high and medium doses of glucocorticoid therapy in remission induction of IgG4-related diseases: a preliminary randomized controlled trial.
    Wu Q; Chang J; Chen H; Chen Y; Yang H; Fei Y; Zhang P; Zeng X; Zhang F; Zhang W
    Int J Rheum Dis; 2017 May; 20(5):639-646. PubMed ID: 28556584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series.
    Cortazar FB; Leaf DE; Owens CT; Laliberte K; Pendergraft WF; Niles JL
    BMC Nephrol; 2017 Feb; 18(1):44. PubMed ID: 28143416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoglobulin-G4-related hypertrophic pachymeningitis with antineutrophil cytoplasmatic antibodies effectively treated with rituximab.
    Popkirov S; Kowalski T; Schlegel U; Skodda S
    J Clin Neurosci; 2015 Jun; 22(6):1038-40. PubMed ID: 25861887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous presentation of granulomatosis with polyangiitis (GPA) and immunoglobulin G4-related disease (IgG4-RD). Leaving an open question: widening the spectrum of a single disease or real overlap?
    Boncoraglio MT; Prieto-González S; Fernandes-Serodio J; Corral-Molina JM; Solé M; Hernández-Rodríguez J
    Mod Rheumatol Case Rep; 2021 Jan; 5(1):108-112. PubMed ID: 33269656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of relapse predictors in IgG4-related disease using multivariate analysis of clinical data at the first visit and initial treatment.
    Yamamoto M; Nojima M; Takahashi H; Yokoyama Y; Ishigami K; Yajima H; Shimizu Y; Tabeya T; Matsui M; Suzuki C; Naishiro Y; Takano K; Himi T; Imai K; Shinomura Y
    Rheumatology (Oxford); 2015 Jan; 54(1):45-9. PubMed ID: 24907151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Azathioprine as successful maintenance therapy in IgG4-related tubulointerstitial nephritis.
    Pozdzik AA; Brochériou I; Demetter P; Matos C; Delhaye M; Devière J; Nortier JL
    Clin Kidney J; 2012 Jun; 5(3):225-8. PubMed ID: 26069770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Relapsing autoimmune pancreatitis type 1: case report].
    Ondrejková A; Kianička B; Nechutová H; Hruška L; Novotný I; Souček M
    Vnitr Lek; 2017; 63(4):277-283. PubMed ID: 28520452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients.
    Ebbo M; Grados A; Samson M; Groh M; Loundou A; Rigolet A; Terrier B; Guillaud C; Carra-Dallière C; Renou F; Pozdzik A; Labauge P; Palat S; Berthelot JM; Pennaforte JL; Wynckel A; Lebas C; Le Gouellec N; Quémeneur T; Dahan K; Carbonnel F; Leroux G; Perlat A; Mathian A; Cacoub P; Hachulla E; Costedoat-Chalumeau N; Harlé JR; Schleinitz N
    PLoS One; 2017; 12(9):e0183844. PubMed ID: 28915275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: multicenter study of treatment efficacy.
    Mealy MA; Wingerchuk DM; Palace J; Greenberg BM; Levy M
    JAMA Neurol; 2014 Mar; 71(3):324-30. PubMed ID: 24445513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Remission of the disease associated/related with immunoglobulin IgG4 accompanied by multiple lymphadenopathy after treatment with rituximab and dexamethasone: a case report].
    Adam Z; Chovancová Z; Nová M; Fabian P; Řehák Z; Koukalová R; Slávik M; Pour L; Krejčí M; Čermák A; Král Z; Mayer J
    Vnitr Lek; 2018; 64(3):290-299. PubMed ID: 29766732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors influencing the relapse risk at steroid dose reduction in myasthenia gravis.
    Scherpbier HJ; Oosterhuis HJ
    Clin Neurol Neurosurg; 1987; 89(3):145-50. PubMed ID: 3665287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of conventional immunosuppressants in relapsing or refractory eosinophilic granulomatosis with polyangiitis: evidence from a Canadian single-centre cohort.
    Doubelt I; Pulenzas N; Carette S; Pagnoux C;
    Clin Exp Rheumatol; 2020; 38 Suppl 124(2):171-175. PubMed ID: 32167871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial.
    Raghu G; Depaso WJ; Cain K; Hammar SP; Wetzel CE; Dreis DF; Hutchinson J; Pardee NE; Winterbauer RH
    Am Rev Respir Dis; 1991 Aug; 144(2):291-6. PubMed ID: 1859050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Additive effect of leflunomide and glucocorticoids compared with glucocorticoids monotherapy in preventing relapse of IgG4-related disease: A randomized clinical trial.
    Wang Y; Zhao Z; Gao D; Wang H; Liao S; Dong C; Luo G; Ji X; Li Y; Wang X; Zhao Y; Li K; Zhang J; Jin J; Zhang Y; Zhu J; Zhang J; Huang F
    Semin Arthritis Rheum; 2020 Dec; 50(6):1513-1520. PubMed ID: 32113839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial.
    Burmester GR; Buttgereit F; Bernasconi C; Álvaro-Gracia JM; Castro N; Dougados M; Gabay C; van Laar JM; Nebesky JM; Pethoe-Schramm A; Salvarani C; Donath MY; John MR;
    Lancet; 2020 Jul; 396(10246):267-276. PubMed ID: 32711802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.